Janus Henderson Group PLC Nuvation Bio Inc. Transaction History
Janus Henderson Group PLC
- $194 Billion
- Q2 2025
A detailed history of Janus Henderson Group PLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 76,700 shares of NUVB stock, worth $283,790. This represents 0.0% of its overall portfolio holdings.
Number of Shares
76,700
Previous 76,700
-0.0%
Holding current value
$283,790
Previous $134,000
11.19%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NUVB
# of Institutions
195Shares Held
168MCall Options Held
2.31MPut Options Held
221K-
Decheng Capital LLC Menlo Park, CA26MShares$96 Million12.78% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$60.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.9MShares$58.8 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA11MShares$40.9 Million46.36% of portfolio
-
Laurion Capital Management LP New York, NY10.2MShares$37.9 Million0.37% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $804M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...